Pulmonary blood volume measured by cardiovascular magnetic resonance: influence of pulmonary transit time methods and left atrial volume

Table 1 Participant characteristics and cardiovascular magnetic resonance anatomic data

	Healthy controls N = 21	Patients N = 37
Sex (n, female/male)	13/8	11/26
Age (years)	61 ± 8	65 ± 13
BSA (m²)	1.9 ± 0.2	2.0 ± 0.2
LV EDV (ml)	147 ± 21	191 ± 49^a
LV ESV (ml)	56 ± 13	97 ± 44^a
LV SV (ml)	89 ± 14	94 ± 19^a
LV EF (%)	61 ± 6	51 ± 11^b
CO (L/min)	5.5 ± 1.2	5.7 ± 1.4
LA max volume (ml)	92 ± 21	116 ± 29
LA min volume (ml)	43 ± 21	67 ± 27
LAV_mean (ml)	68 ± 20	91 ± 27
Etiology (n)	Not applicable	Ischemic heart disease (14), Idiopathic heart failure (8), heart failure with preserved ejection fraction (8), heart transplanted (2), dilated cardiomyopathy (2), myocarditis (1), heart failure due to chemotherapy (1), pericardial cyst (1)

BSA body surface area; LV left ventricular; EDV end-diastolic volume; ESV end-systolic volume; SV stroke volume; EF ejection fraction; CO cardiac output; LA left atrium; LAV_mean left atrial mean volume; CMR cardiovascular magnetic resonance
^aLeft ventricular volumetry by CMR available in 36 of 37 patients
^bEF by echocardiography in one patient

ISSN: 1532-429X